73 related articles for article (PubMed ID: 7574778)
1. [Antitumor effect of MMC mixed in Beriplast P].
Yano K; Matsuoka H; Baba H; Konoe S; Seo Y; Saito T; Tomoda H
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1629-31. PubMed ID: 7574778
[TBL] [Abstract][Full Text] [Related]
2. Advantages and safety of local treatment with MMC/Beriplast P for cancer tumors.
Matsuoka H; Yano K; Katsuta Y; Morita M; Kounoe S; Seo Y; Saito T; Tomoda H
Cancer Chemother Pharmacol; 1996; 38(6):508-12. PubMed ID: 8823491
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacodynamic study of mitomycin C mixed with fibrin glue for treatment of malignant brain tumors].
Kawasaki H; Shimizu T; Takakura K; Umezawa Y
No Shinkei Geka; 1994 Sep; 22(9):819-25. PubMed ID: 8090263
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice.
Fujita T; Tamura T; Yamada H; Yamamoto A; Muranishi S
J Drug Target; 1997; 4(5):289-96. PubMed ID: 9169985
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study on local attachment of Beriplast P membrane including MMC].
Takahashi Y; Minami S; Ohta T; Suga T; Fujioka N; Mai M
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1944-6. PubMed ID: 1908661
[TBL] [Abstract][Full Text] [Related]
6. [An experimental study on antitumor effect of MMC-fibrin glue mixture].
Tanaka T; Yamana H; Fujita H; Ono T; Tou Y; Fujii T; Uhi T; Shirouzu K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1400-2. PubMed ID: 8854763
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic study of intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles].
Liang H; Tang HW; Hao XS; Sun H; Li W
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):412-5. PubMed ID: 16188126
[TBL] [Abstract][Full Text] [Related]
8. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates.
Ishiki N; Onishi H; Machida Y
Int J Pharm; 2004 Jul; 279(1-2):81-93. PubMed ID: 15234797
[TBL] [Abstract][Full Text] [Related]
10. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
Qu QL; Zhang YG; Yang LZ; Sun L
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
[TBL] [Abstract][Full Text] [Related]
11. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
12. [Effects of IgG-Fc-mitomycin C conjugate on cancer cells].
Baba E
Hokkaido Igaku Zasshi; 1996 Mar; 71(2):271-81. PubMed ID: 8641681
[TBL] [Abstract][Full Text] [Related]
13. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
Xi-Xiao Y; Jan-Hai C; Shi-Ting L; Dan G; Xv-Xin Z
Regul Toxicol Pharmacol; 2006 Dec; 46(3):211-7. PubMed ID: 17010489
[TBL] [Abstract][Full Text] [Related]
14. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
Cheung RY; Rauth AM; Ronaldson PT; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2006 Apr; 62(3):321-31. PubMed ID: 16330194
[TBL] [Abstract][Full Text] [Related]
15. DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.
Saeki S; Nishiyama M; Toge T
Hiroshima J Med Sci; 1995 Sep; 44(3):55-63. PubMed ID: 8567314
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres.
Rump AF; Woschée U; Theisohn M; Fischbach R; Heindel W; Lackner K; Klaus W
Eur J Clin Pharmacol; 2002 Oct; 58(7):459-65. PubMed ID: 12389068
[TBL] [Abstract][Full Text] [Related]
17. Effect of intraurethral Mitomycin-C on healing and fibrosis in rats with experimentally induced urethral stricture.
Ayyildiz A; Nuhoglu B; Gülerkaya B; Caydere M; Ustün H; Germiyanoglu C; Erol D
Int J Urol; 2004 Dec; 11(12):1122-6. PubMed ID: 15663686
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
Sakamoto N; Toge T; Nishiyama M
Hiroshima J Med Sci; 1997 Jun; 46(2):67-73. PubMed ID: 9232934
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor activity of mitomycin C conjugated with anti-alpha-fetoprotein antibody by a novel method of conjugation.
Kato Y; Tsukada Y; Hara T; Hirai H
J Appl Biochem; 1983; 5(4-5):313-9. PubMed ID: 6207159
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
